Praluzatamab ravtansine, 1mg

Praluzatamab ravtansine, 1mg

Depatuxizumab mafodotin, 1mg

Depatuxizumab mafodotin, 1mg

Praluzatamab ravtansine, 1mg*5

19.336,31 RON
SKU
SKM_D4039_1mg*5

Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAbconjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAbconjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.